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PURPOSE. Optic nerve hypoplasia (ONH) is the most common cause of childhood congenital
blindness in developed nations, yet the fundamental pathobiology of ONH remains unknown.
The objective of this study was to employ a ‘face validated’ murine model to determine the
timing of onset and the pathologic characteristics of ONH.
METHODS. Based on the robust linkage between X-linked CASK haploinsufficiency and
clinically diagnosed ONH, we hypothesized that heterozygous deletion of CASK (CASK(þ/))
in rodents will produce an optic nerve pathology closely recapitulating ONH. We
quantitatively analyzed the entire subcortical visual system in female CASK(þ/) mice using
immunohistochemistry, anterograde axonal tracing, toluidine blue staining, transmission
electron microscopy, and serial block-face scanning electron microscopy.
RESULTS. CASK haploinsuffiency in mice phenocopies human ONH with complete penetrance,
thus satisfying the ‘face validity’. We demonstrate that the optic nerve in CASK(þ/) mice is
not only thin, but is comprised of atrophic retinal axons and displays reactive astrogliosis.
Myelination of the optic nerve axons remains unchanged. Moreover, we demonstrate a
significant decrease in retinal ganglion cell (RGC) numbers and perturbation in retinothalamic
connectivity. Finally, we used this mouse model to define the onset and progression of ONH
pathology, demonstrating for the first time that optic nerve defects arise at neonatally in
CASK(þ/) mice.
CONCLUSIONS. Optic nerve hypoplasia is a complex neuropathology of the subcortical visual
system involving RGC loss, axonopathy, and synaptopathy and originates at a developmental
stage in mice that corresponds to the late third trimester development in humans.
Keywords: optic nerve hypoplasia, CASK, axonopathy, synaptopathy
Childhood blindness (prevalence ~0.7/1000) poses a hugesocioeconomic challenge due to early affliction.1 Optic
nerve hypoplasia (ONH) is the most common form of optic
neuropathy and accounts for 15% to 25% of childhood
blindness in developed nations.2 Optic nerve hypoplasia is
not always associated with vision loss,2 and may be associated
with other ophthalmologic manifestations like microphthalmia,
aniridia, nystagmus, and strabismus.3 Fundoscopy detects ONH
as a small pale optic disc and there may be an increase in the
ratio of disc-macula to disc diameter (DM:DD, the ratio of the
horizontal distance between the center of the optic disc and
the macula to the mean diameter of the optic disc).3
Sometimes, the optic disc also appears to be surrounded by
double rings in fundoscopic images.4 The first case of ONH was
described in 1884 and at present it is classified into three
distinct forms: (1) ONH simplex, (2) septo-optic dysplasia
(SOD), and (3) septo-optic-pituitary dysplasia.2
The etiopathogenesis of ONH and its differences from
perinatal optic nerve atrophy (ONA) remains unclear.5 Maternal
age and primiparity are the most consistent risk factors
associated with ONH.6 Although ONH has been observed in a
murine model of fetal alcohol syndrome,7 large scale studies
have failed to uncover evidence for association of ONH with
maternal consumption of alcohol and other recreational drugs.8
Most cases of ONH are sporadic in nature, with only few genes
that have been directly implicated. For instance, mutations in
HESX1 may be associated with SOD in limited number of
cases.9,10 Similarly mutations in transcription factors like PAX6,
ATOH7, SOX2, OTX2, and VAX1 have also been clinically
associated with ONH.11 Involvement of transcription factors in
a developmental disorder is not surprising because they
regulate several cell biological pathways crucial for cell survival
and differentiation. Mutations in these genes in animal models
therefore produce numerous phenotypes including those in
eyes, most notably microphthalmia/anophththalmia.9,12,13
Large scale cellular loss in the retinal ganglion cell (RGC) layer,
producing optic nerve agenesis or dysgenesis, has also been
noted.14 Besides transcription factors, genes involved in
metabolism, RNA splicing, chromatin remodeling, and dytro-
glycan glycosylation have also been reported to be associated
with occasional ONH.11 For many of these genes either a good
mouse model is not available or the mouse model does not
accurately replicate the human conditions.11,15,16
The majority of cases of ONH, however, have no defined
genetic association and there is a paucity of genotype–
phenotype correlation of patients with ONH.6 Mutations in
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the X-linked gene CASK encoding a peripheral scaffolding
protein have been strongly associated with ONH17 and
mutations in CASK therefore represent a potential avenue to
generate a novel model of ONH for mechanistic and pathologic
evaluation.
CASK was initially described as a candidate gene for X-
linked ONA18 and mutations in CASK are associated with
ONH.17,19,20 We report new subjects with CASK mutations and
ONH, further confirming the association, and we show that
heterozygous deletion of CASK causes optic nerve pathology
indicating that these phenotypes represent CASK loss of
function. Furthermore, our results demonstrate that the optic
nerve of CASK(þ/) mice have atrophic axons with increased
interaxonal space and astrogliosis. The numbers of retinogeni-
culate synapses are reduced with specific loss of smaller
boutons; furthermore the large boutons exhibit an overall
decrease in number of active zones. In retina, we observe a
decrease in number of RGCs in CASK(þ/) mice. Finally, we
demonstrate that the optic nerve pathology in CASK(þ/) mice
occurs very early in postnatal rodent developmental, a stage
considered equivalent to the late third trimester and neonatal
period of human fetal development.21 Haploinsufficiency of
CASK therefore produces a combination of retinopathy, optic
nerve pathology, as well as synaptopathy. Thus, our results
demonstrate that a face validated mouse model provides new
insight into the pathogenesis and timing of ONH.
METHODS
Ethical Statement
The Virginia Tech Universities institutional review board
approved the collection and use of data from subjects.
Informed consent was obtained from the family prior to
participation. All animal work was done in accordance to with
the guidelines for the animal care of laboratory animals issued
by Virginia Tech and adhered to the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Identification of a Splice Mutation in CASK
We performed whole-exome sequencing (WES) on genomic
DNA of the patient. Using the Illumina HiSeq2000 platform
(Illumina, San Diego, CA, USA) and the acquired reads were
aligned to the reference human genome (UCSC Genome
Browser hg19. Data processing was performed with the
Genome Analysis ToolKit (GATK) and variants were annotated
using Annovar (http://annovar.openbioinformatics.org/en/lat
est/, in the public domain) and an in-house developed web
interface called Annotate-it.22 In the first stage, we analyzed all
genes that were previously associated with microcephaly. The
heterozygous splice variant in exon 24 (NM_001126054:
exon24:c.2233þ1G>A) of CASK, was predicted to lead to
exon skipping, and was confirmed by Sanger sequencing. The
variant arose de novo and was absent in both biological
parents. To further test the effect of the mutation, we
performed PCR with primers in exons 25 and 23 on cDNA
made from RNA extracted from Epstein-Barr virus–transformed
lymphocytes of the patient.23 The RT-PCR on the patient
clearly showed two bands and sequencing of the smallest band
confirmed exon 24 skipping.
Mouse Breeding and Genotyping
CASK(þ/) female mice, generated in house,24 were crossed
with C57BL6 male mice to propagate CASK(þ/) female pups
and their CASK(þ/þ) female littermates. Genotyping was done
using a PCR-based method with following primer pair
(forward: TTTGGGGACTAGATGGGTGTGGTG, reverse:
CTTGGTCGCAGCTTGGGAGTA).
Immunohistochemistry (IHC)
Mice were anesthetized and perfused with PBS and then 4%
paraformaldehyde (PFA). Brain, retina, or optic nerve were
dissected and postfixed in 4% PFA. Tissues were cryopreserved
in 30% sucrose before embedding in Neg50 matrix (Richard-
Allan Scientific, San Diego, CA, USA) and cryosectioned using
Leica Cryostat (Leica Biosystems, Wetzlar, Germany) to
generate 16- to 25-lm thick tissue sections. Sections were
permeabilized and blocked with 0.25% Triton X-100 and 5%
BSA in PBS. Immunostaining were performed using primary
antibodies at an appropriate concentration followed by
labeling with fluorophore conjugated secondary antibodies.
Primary antibodies include: Calretinin (rabbit polyclonal Ab,
Cat. No. AB5054, 1:2000; Millipore, Billerica, MA, USA), RNA-
binding protein with multiple splicing (RBPMS; rabbit poly-
clonal Ab, Cat. No. 1830, 1:500; PhosphoSolution, Aurora, CO,
USA), glial fibrillary acidic protein (GFAP; mouse monoclonal
Ab, Cat. No. 75240, 1:1000; Neuromab, UC Davis, CA, USA).
Secondary antibodies include: Alexa Fluor 488 (goat anti-rabbit,
Cat. No. A-11008, 1:1000; Invitrogen) and Dylight 633 (anti-
mouse IgG, Cat. No. 35512, 1:1000; Thermo Scientific,
Waltham, MA, USA). Sections were mounted with VectaShield
containing 40,6-diamidino-2-phenylindole (DAPI; Vector Labo-
ratories, Burlingame, CA, USA) and were imaged using a Zeiss
700 or 710 laser scanning confocal microscope (Oberkochen,
Germany).
Immunoblotting
Optic nerves dissected from young female wild-type and
CASK(þ/) mice (postnatal day [P] 40) were boiled in sample
buffer and proteins separated by 8% SDS-PAGE. Proteins were
then transferred onto nitrocellulose membrane and blocked in
5% skimmed milk for 2 hours and incubated using appropriate
primary and secondary antibodies. For quantitative immuno-
blots, secondary antibodies conjugated with fluorophore were
used and images were captured using appropriate filter in
Chemidoc (Biorad, Hercules, CA, USA). Antibodies used are
CASK (mouse monoclonal Ab, Cat. No. 75000, 1:1000;
NeuroMab), neurofilament-associated antigen (NFAA; mouse
monoclonal Ab, Cat. No. 3A10, 1:1000l; DSHB, Iowa City, IA,
USA), and tubulin (mouse monoclonal Ab, Cat. No. 12G10 anti-
alpha-tubulin, 1:1000; DSHB).
Optic Nerve Samples Preparation for Toluidine
Blue Staining and Transmission Electronic
Microscopy (TEM)
Mice were anesthetized and perfused with PBS and then
sodium cacodylate (NaCa) buffer (2% glutaraldehyde/2% PFA
[2G/2PF] in 0.1 M sodium cacodylate in PBS, pH 7.4). After
perfusion, optic nerves were dissected and immersed in NaCa
buffer overnight and then put in 2% OSO4 for 2 hours for
postfixation. Dehydration was achieved by sequentially adding
15% to 100% ethanol. Samples were embedded in 100% epoxy
resin for 24 hours and then placed in oven at 588C for 2 days.
Sectioning of samples and successive toluidine blue stain or
TEM was performed at Virginia-Maryland College of Veterinary
Medicine at Virginia Tech.
G-Ratio Distribution Spectra
G-ratio, defined as the ratio of inner axonal diameter to the
outer axonal diameter (including myelin sheath),25 of 240 optic
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nerve axons were measured on TEM images (34000) using
ImageJ software (http://imagej.nih.gov/ij/; provided in the
public domain by the National Institutes of Health, Bethesda,
MD, USA). The measurements of inner and outer axonal
diameters (d) were calculated from inner and outer axonal
areas (a), respectively, to reduce error because the sections
were not perfectly round in shape, where d’ 2
ﬃﬃ
a
p
p
. Probability
density distribution of G-ratio values was plotted based on a
smooth kernel density estimate by using the function of
‘‘SmoothHistogram’’ offered in the software of Mathematica
(Wolfram, Champaign, IL, USA). The smooth kernel density
estimate based probability density function is given by a
linearly interpolated version of
1
nh
Xn
i¼1
k
x  xi
h
 
;
where x is the value of G-ratio, n is the sample size, bandwidth
h is selected as ‘‘Automatic’’ and kernel smoothing function
k(x) was given by ‘‘Gaussian’’ ( 1ﬃﬃﬃﬃ
2p
p e
u2
2 , u  R) in Mathematica.
Above functions can be found in any advanced level statistics
textbook. The Kolmogorov-Smirnov test was used to determine
if the two probability density distributions are from the same
population.
Serial Block-Face Scanning Electron Microscopy
Control and CASK(þ/) mice were transcardially perfused with
PBS and 4% paraformaldehyde/2% glutaradehyde in 0.1 M
cacodylate buffer. Brains were removed, 300-lm coronal
sections were obtained using vibratome and dorsolateral
geniculate nucleus (dLGN) were dissected. Tissues were
stained, embedded, sectioned, and imaged as described
previously26 by Renovo Neural, Inc. (Cleveland, OH, USA).
Images were acquired at a resolution of 6 nm/pixel and image
sets included greater than 200-serial sections (with each
section representing 65 nm in the z axis). Data sets were
analyzed in TrakEM2 and retinal terminals were unequivocally
identified by the presence of synaptic vesicles and pale
mitochondria.26,27
Intraocular Injections of Anterograde Tracers and
Quantification
Intraocular injection of cholera toxin subunit B (CTB)
conjugated to AlexaFluor 555 (Invitrogen) was performed as
described previously.28 After 2 days, mice were euthanized,
perfused with 4% PFA, and brains were dissected and postfixed
in 4% PFA overnight. On a vibratome, 80- to 100-lm coronal
slices were sectioned and mounted using VectaShield (Vector
Laboratories). Confocal Z-stack images from coronal dLGN
sections were acquired on a Zeiss LSM 700 confocal
microscope. Z-stacks were obtained with a Zeiss 320 Plan-
Apochromat objective and contained 14- to 20-optical sections
(in 3-lm steps). Confocal images were obtained from four adult
CASK(þ/) mutants and four littermate controls. The size and
quantity of synapses in each dLGN (from the center of its
rostral-caudal extent), was performed in ImageJ, blind to the
genotype of the sample. Five images of each dLGN Z-stacks
were randomly selected, images were manually thresholded,
and the quantity and surface area of the isolated puncta was
measured. Data was exported into Microsoft Excel (Redmond,
WA, USA), binned by size, and plotted into a histogram.
Cell Counts and Lamina Quantification
Cell counts were performed on 16-lm cryosectioned 4% PFA-
fixed retinal tissue as described previously.29,30 Slides were
stained with DAPI (diluted 1:5000 in PBS) for 60 seconds and
then mounted with VectaShield (Vector Laboratories). Images
of central retina were acquired on a Zeiss LSM 700 confocal
microscope or a Zeiss Axio Imager A2 fluorescent microscope.
All DAPI and RBPMS-positive cells in the ganglion cell layer
were counted manually under320 objective. Cell counts were
analyzed from at least four animals for each age and genotype.
Five images per retina per mouse were analyzed. Retinal
lamination was quantified for each genotype in the central
retina in DAPI-stained retinas using ImageJ.
Description of Coarse and Fine Axons
Because the axons in CASK(þ/) mice are overall small, it is
difficult to apply the same threshold for fine and coarse axons
on these mice as with those of wild type. On examining the
distribution of the axonal area we found they are distributed in
a bimodal manner (2 different slopes; see Fig. 3C). Because the
CASK(þ/) axons were smaller we applied a different threshold
for each genotype, the value of the threshold was the point
where the data points start to lose linearity (see Fig. 3C).
RESULTS
Mutations in the CASK Gene are Associated With
ONH
Mutations in the CASK gene have been previously associated
with ONH, ONA, and glaucoma.17,20 Here we describe a 3-year-
old girl with a heterozygous splice site mutation in CASK
(NM_001126054:exon24:c.2233þ1G>A) leading to skipping of
exon 24 that exhibits microcephaly, global developmental
delays, and spastic quadriparesis (Figs. 1A–C). Magnetic
resonance imaging (MRI) did not reveal any specific midline
structural defect as seen in septo-optic dysplasia or any white
matter lesion (Figs. 1D, 1E). Although truncated proteins may
be generated in the subject from the mutated CASK allele, they
are unlikely to be functional in absence of the Hook motif and
the guanylate kinase domain, especially because the interdo-
main interaction with the guanylate kinase domain is critical
for proper folding and function of membrane-associated
guanylate kinase proteins.31,32 Furthermore, the transcripts
with premature stop codon are likely to get degraded due to
nonsense-mediated decay. Thus, the pathogenic mutation
described here is likely to produce haploinsufficiency. The
girl displays ONH and other ophthalmic conditions including
hyperopia, nystagmus, and infantile esotropia. Fundoscopy
revealed a bilaterally normal anterior segment, however both
optic discs were pale, small, and hypoplastic (Fig. 1F).
Hypoplastic optic nerves have also been observed in both
MRI and fundoscopic examination of a second girl with
heterozygous nonsense mutation in the N-terminal calcium/
calmodulin-dependent kinase domain of CASK (c.661G>T;
p.G221X [het]) (personal communications). This highly
premature stop codon would either result in a nonfunctioning
small peptide or no CASK protein product due to nonsense-
mediated decay. The second girl displays severe visual
impairment as well as nystagmus and intermittent exotropia
(Mukherjee K, personal communications, 2017). These obser-
vations, and a previously published report,17 indicate that
heterozygous loss of function mutations of CASK gene
associates with ONH.
Heterozygous Deletion of CASK in Mice Produces
Optic Nerve Pathology
To test whether heterozygous mutation of CASK is sufficient to
alter the ON and subcortical visual system in mice, we analyzed
CASK Haploinsufficiency Produces ONH IOVS j October 2017 j Vol. 58 j No. 12 j 5487
female mouse mutants with a single allele of CASK deleted
(CASK(þ/) mice). Previously, we documented that CASK(þ/)
mice exhibit secondary microcephaly, disproportionate cere-
bellar hypoplasia, as well as thinning and hypoplasia of the
optic nerve indicating that it recapitulates the human
phenotypes associated with CASK mutation or loss.24 We
examined optic nerves following toluidine blue staining of
semithin cross-sections—a method that labels myelin and
FIGURE 1. Genetic, brain, and retinal alterations associated with heterozygous CASK mutation. (A) Sanger sequences showing the de novo
heterozygous splice variant in exon 24 (NM_001126054:exon24:c.2233þ1G>A). (B) The schematic of exon skipping. (C) CASK. Reverse-
transcription PCR with primers (arrows in panel B) in exons 25 and 23 on cDNA of the patient and subsequent sequencing confirmed exon 24
skipping (a lower band indicated by the arrow compared with control). (D, E) Magnetic resonance images of brain indicate no specific midline
structural defect or white matter lesion. (F) A fundoscopic image from this haploinsufficient 3-year-old girl who was diagnosed with ONH. Note the
pale, hypoplastic optic disc (as compared with a fundoscopy image from a 3.5-year-old girl without ONH; Supplementary Fig. S1).
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allows the quantification of myelinated retinal axons in the ON.
Surprisingly, besides being small (Figs. 2A, 2B), the optic nerve
displayed an overall decrease in axonal density (Figs. 2C, 2D).
The number of axons in a given area was reduced by
approximately 25% and the interaxonal space was expanded
(Fig. 2E). Histopathology on a single ONH case suggested that
there might be an increase in number of astrocytes in ONH.33
We therefore examined the optic nerve of CASK(þ/) mice for
levels of GFAP, a marker of astrocytes. We found a large
increase in the GFAP staining in the optic nerve of CASK(þ/)
mice compared with sex-matched littermate controls suggest-
ing that haploinsufficiency of CASK gene may be associated
with increased astrocytes in optic nerve (Fig. 2F).
Axonopathy is Present in Optic Nerves of CASK(þ/)
Mice
A reduced axonal density in the CASK(þ/) mice optic nerve
may reflect not only a loss of RGC axons, but also a thinning of
individual axons of RGCs. Very small atrophic axons may
escape counting from toluidine blue–stained semithin sections.
We therefore performed TEM on cross sections of ON and
quantified axons in CASK(þ/) mutants (Figs. 3A, 3B). Indeed,
our data indicate that the cross-sectioned area of individual
axons was significantly decreased in CASK(þ/) mice (Figs. 3A–
D), with the presence of many very small axons in mutant ON.
Because optic nerves contain populations of coarse and fine
retinal axons,34,35 we measured the area of coarse and fine
axons separately. Our data demonstrate that the area of both
the types of axons are decreased in CASK(þ/) mice (Figs. 3E,
3F).
We next turned our attention to myelin content in mutant
ON, to assess whether the reduction in ON diameter reflects
myelin loss. G-ratio distribution spectra, which assess the ratio
of axonal diameter to the diameter of the myelinated axon,25
were applied to compare myelin of wild-type littermate mice
with that of the CASK(þ/) mice. The probability density
distribution of G-ratios in mutant mice appears shifted to the
left, indicating a higher myelin-to-axon ration compared with
controls (Fig. 3G). We interpret these results to indicate that
while CASK haploinsufficiency influences axon diameter it
FIGURE 2. CASK(þ/) ON display reduced axons and increased astrogliosis. (A, B) Representative images of semithin cross section of optic nerves
from indicated genotype stained with toluidine blue. Scale bar: 100 lm. (C, D) Higher magnification of toluidine blue–stained semithin optic nerve
sections of indicated genotype. Note that CASK(þ/) optic nerve has lesser axonal density and increased interaxonal space (indicated by arrows). (E)
Axonal density from optic nerve of four different mice is quantified, data is plotted as mean 6 SEM. (*P < 0.05). (F) Glial fibrillary acidic protein
immunolabeling of mutant (þ/) and control (þ/þ) optic nerves. Scale bar: 50 lm. (G) Quantification of pixels of GFAP per unit area of optic nerve
has been plotted as mean 6 SEM; n¼ 4 mice.
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FIGURE 3. CASK(þ/) ON display axonal thinning. (A, B) Representative transmission electron micrograph of optic nerves from indicated genotypes.
(C) Scatter plot of individual axonal areas from control and mutant ON obtained from three mice per genotype. Arrows indicate the ‘‘threshold’’
where the data points start to lose linearity (correlation coefficient R2 value starts and continue decreasing). Axons with area values that are greater
than or equal to the threshold are considered as coarse axons, and axons with volume values that are smaller than the threshold are considered as
fine axons. Threshold value for (þ/þ) is 4 and (þ/) is 2 lm2. (D) Mean and SDs of all axons from (C) are plotted, N¼240. (E, F) Comparisons of fine
and coarse axons area in mutant (þ/) and control (þ/þ) ON (n ¼ 3 mice per genotype). Data are plotted as mean 6 SD; N ¼ 240. (G) G-ratio
probability density distributions of myelinated optic nerve axons of (þ/þ) and (þ/), N¼ 240. (H) Immunoblot of optic nerves from six randomly
selected animals of indicated genotype. The antigens are indicated, NFAA is neurofilament associated antigen, which is axonal marker. (I)
Quantitation of the blots normalized to ponceau staining. Data are relative to wild-type levels and is plotted as mean 6 SEM, n¼ 3 (all panels, *P <
0.05; **P < 0.01).
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does not appear to limit the development of compact myelin
on these axons.
Because CASK is an X-linked gene and is therefore subject to
X-linked random inactivation, two types of RGCs exist in
CASK(þ/) mutant mice, those which produce CASK and those
which do not. Differences in axonal diameter of CASKþ and
CASK RGCs should produce an increased variability in axonal
diameter within the ON in these studies. We therefore
measured the mean of deviation (how far on average all values
are from the mean), which is a measure of variability of the
axonal areas. Surprisingly, the mean deviation for the axonal
area in CASK(þ/) optic nerve is smaller than the wild type
(Supplementary Fig. S2) indicating a tighter distribution.
Overall, the distribution of the area of individual axons was
smaller but roughly parallel in CASK(þ/) mice and their sex-
matched wild-type littermate indicating random inactivation of
deleted CASK allele had no bearing on the development or
health of individual axons (Fig. 3C). Indeed, we have
previously documented that CASK promotes postnatal brain
growth in a non-cell autonomous manner24 (i.e., CASKþ and
CASK cells are equally affected). We therefore tested if there is
specific loss of only CASK negative axons in CASK(þ/) mice.
Specific loss of axons from cells, which are CASK negative will
lead to an artificial skewing of RGCs toward being CASK
positive. To determine if such is the case, we blotted optic
nerve homogenates for CASK, an axonal marker NFAA, and a
general cellular marker tubulin-a (Fig. 3H). Our data suggest
that there is a slight reduction in NFAA, which did not reach a
statistical significance. Our data thus indicate that the decrease
in axonal count from toluidine blue–stained section may
indeed be an overestimate due to omission of very small gauge
atrophic axons. However, the CASK content within optic nerve
was approximately 47%. Secondary selection of CASK positive
RGCs would have produced a favorable skewing of X-
chromosome inactivation among RGCs.36 Under such circum-
stances, we would not expect to see a decrease in CASK
protein amount (Fig. 3I). Therefore, our data suggest that ONH
in CASK(þ/) mice may not be due to specific loss of CASK
negative axons.
Retinogeniculate Synaptopathy is Observed in
CASK(þ/) Mice
Axonopathy may alter axonal transport and produce defects in
synapse formation.37 CASK has also been shown to be both a
trafficking molecule38 and a synaptic scaffolding protein. It is
also known to interact and phosphorylate presynaptic
adhesion molecule neurexin in an activity dependent man-
ner.39,40 Neurexins are synaptogenic,41 therefore, we exam-
ined retinogeniculate synapses in CASK(þ/) mice. It is
pertinent to note in previous animal model studies involving
worms, flies, and mice, deletion of CASK did not produce
defects in synapse formation.42–44 We initially examined RGC
terminals in thalamus by anterogradely labeling RGCs with
intraocular injection of fluorescently conjugated cholera toxin
subunit B. We found that there is a significant reduction in
small diameter RGC terminals in CASK(þ/) mice compared
with wild-type littermate (Fig. 4A). Because of this change in
terminal populations, we examined the ultrastructure of RGC
terminals using serial block-face scanning electron microscopy.
With this technique, retinal terminals can be unequivocally
identified based on their ultrastructural morphology.42 Overall
synapse volume in CASK(þ/) mice remained largely unchanged
(Figs. 4B–D). In order to test if the defect associated with CASK
haploinsufficiency is restricted to smaller synapses only or not,
we carefully analyzed the ultrastructure of all reconstructed
RGC terminals. Our data demonstrate that the number of active
zones (release sites) per unit volume of RGC terminals are
reduced in CASK(þ/) (Figs. 4E, 4F). Furthermore, smaller
terminals have significant increase in volume (Figs. 4G, 4H).
Thus, besides the thinning of axons produced by CASK
haploinsufficiency we also observed defects in retinogenicu-
late synapse morphology and ultrastructure.
RGC Numbers are Reduced in CASK(þ/) Mice
CASK is present in all retinal cells45 and because we detected
both a thinner optic nerve and a lowered axonal density in
optic nerve of CASK(þ/) mice, we next examined if there was
also a loss of retinal integrity or RGCs in CASK(þ/) mice.
Immunolabeling mutant and control retinal cross sections with
antibodies against Calretinin (Calr) (Fig. 5A), revealed that the
general cytoarchitecture and laminated structure of the retina
was preserved in the absence of CASK. In an order to be
comprehensive in our analysis we also measured the thickness
of other layers of the retina to evaluate if these layers are
affected by CASK loss. Our data indicate the lamination of
retinal layers is not perturbed in CASK(þ/) mice (Supplemen-
tary Fig. S3).
To assess whether there was a specific loss of retinal
ganglion cells in CASK(þ/) mice we counted the total number
of cells within the ganglion cell layer of the retina, by labeling
nuclei with DAPI and staining for RBPMS, a RNA binding
protein selectively expressed by RGCs in the rodent retina(Fig.
5A). Together these data reveal a significant loss of RGCs in
CASK(þ/) mutants (Figs. 5A, 5B). Taken together, we find that
ONH in CASK(þ/) mice is a complex developmental disorder
involving a decrease in the number of RGCs, thinning of
individual axons, reactive astrogliosis within the ON, and
alterations in retinogeniculate synapses. Thus, mutation of
CASK appears to phenocopy many of the features observed in
human patients with ONH, and therefore represents an
appropriate mouse model to elucidate the mechanisms
underlying ONH.
ONH Develops Postnatally in CASK(þ/) Mice
The first mechanistic question regarding ONH pathogenesis
that has eluded our understanding is when exactly the disease
is initiated. The decrease in RGCs and their axons could occur
pre- or postnatally. While it is difficult to parse these
differences out in humans, in this mouse model the difference
can be studied by observing ON diameter throughout
development. We therefore examined toluidine blue–stained
semithin section of CASK(þ/) and control optic nerves during
the first 3 weeks of postnatal mouse development (Fig. 6A). It
is important to point out that the first 2-postnatal weeks of
rodent development correspond to developmental milestones
that occur in the third trimester of human fetal development.21
Moreover, neonatal mice do not open their eyes until the end
of the second postnatal week of development. Surprisingly, the
ON of P1 CASK(þ/) mice was of similar size to that of the wild-
type controls (although, a slight trend toward being smaller
was observed). A more clear and significant difference
between the size optic nerves became apparent by the end
of the first week of postnatal development and the difference
from the wild type reaches the difference observed in adults by
P22 (Fig. 6B). Although myelinogenesis starts around P5 in
mouse ON it peaks during the third and fourth postnatal
week.46 By P22 myelinated axons are easily quantifiable in the
ON. To confirm that the decrease in axonal density occurs at an
early age and not as a part of later degeneration, we examined
the number of axons in P22 optic nerve per unit area. Our data
indicate that axonal density is already reduced (at par as noted
in adults Fig. 2C) by this stage suggesting that CASK-linked
ONH can clearly be classified as a developmental and not a
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FIGURE 4. CASK(þ/) mice display a decrease number of retinogeniculate synapses and a reduced number of active zones in the remaining synapses.
(A) Quantification of the area of retinal terminals in dLGN by anterograde CTB-labeling. Red arrows represent distinct CTB-labeled retinal terminals
of different sizes. Data represents mean 6 SEM, n ¼ 4. (B, C) Representative image of Serial Block-Face Scanning Electron Microscopy (SBFSEM)
ultramicrograph with a retinogeniculate presynapse (identified by presence of pale mitochondria indicated with yellow arrows) labeled red and a
postsynapse labeled green. Examples of reconstructed retinal terminals from a series of SBFSEM micrographs are shown on the right. Volumetric
quantitation (D), number of active zones (E), and active zone density (F), of the presynaptic boutons from 60 reconstructed retinogeniculate
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degenerative process. Because, we observed thinning of optic
nerve only from P6, we repeated the measurement of RGCs at
P6. Our data indicates that at P6 there is no reduction in RGC
numbers in CASK(þ/) mice, indicating a potential loss of RGCs
early in development (Figs. 6D, 6E). Overall, our data
demonstrate that ONH in CASK(þ/) mice occurs early in
postnatal development (P6–P22), prior to the full maturation
of the subcortical visual system.
DISCUSSION
Optic nerve hypoplasia is the most common cause of
childhood blindness in developed nations, and its prevalence
is growing at an alarming rate.47 A validated genetic animal
model of ONH recapitulating the clinical condition with high
fidelity will serve not only as a necessary tool to understand the
mechanism of disease pathogenesis, but also to test potential
therapeutic interventions. Optic nerve hypoplasia may occur
with midline defects as observed in SOD, with other brain
malformations like atrophic brain or even as isolated condi-
tion.6 The coincidence of ONH with other brain malformation
is not surprising given that the retina and optic nerves are a
part of our central nervous system and subject to the same
developmental processes as the brain. Therefore, a clear
understanding of ONH may also help unlock the pathophys-
iology of other neurodevelopmental disorders. In fact, subjects
with ONH display a high incidence of autistic phenotype such
as stereotypy.48,49 In this regard, mutations in CASK gene as a
causal factor for ONH is particularly important because CASK
mutations are also known to produce autistic traits.47 CASK
directly binds and phosphorylates neuronal adhesion molecule
neurexin.39,40 It is pertinent to note that mutations in both
neurexins and their transsynaptic interacting partners also are
associated with autism.50 Despite known interactions between
CASK and neurexin, no synaptic ultrastructural defect has been
shown to be associated with CASK mutation in any animal
model. Here, we show for the first time clear morphologic
defects at retinogeniculate synapse involving changes in size
and number of release site. Such changes align with the idea
that CASK may be involved in trafficking of molecules and/or
acts as a molecular scaffold at the synapse. Although it may also
be possible that changes in synapses reflect the atrophy in
axons. Mutations in the CASK gene are also associated with
postnatal microcephaly.24 It is possible to argue that ONH may
simply be a part of microcephaly. However, other monogenic
syndromes associated with postnatal microcephaly such as
Rett or Angelman syndrome do not present with ONH,51,52
indicating that ONH is an independent manifestation of CASK
mutation.
CASK is a membrane associated guanylate kinase protein,
which interacts with a large number of other molecules.
Specifically, CASK has been considered to be a synaptic
scaffolding molecule both at the pre- and postsynaptic
FIGURE 5. Decreased number of retinal ganglion cells in CASK(þ/) mice. (A) Immunostaining of retina with antibodies against calretinin reveals
normal lamination in CASK(þ/) mutants at P26. (B) Representative images of retinas stained with DAPI and RBPMS (a marker of RGCs) reveal a
significant loss of cells in the ganglion cell layer in CASK(þ/) mutants compared with controls. Scale bar: 25 lm. Lower panel is a grayscale image
for better visualization. (C) Quantition of cells in the ganglion cell layer in indicated staining. (*P < 0.05). Data are relative to wild-type levels and is
plotted as mean 6 SEM, n¼ 4.
synapses (SBFSEM analysis) from control and mutant mice. Data represent mean 6 SEM, n ¼ 3 mice per genotype. (*P < 0.05; **P < 0.01). (G)
Scattered plot of terminal volumes showing two linear regressions for (þ/þ) and (þ/). Arrows indicate the threshold where the data points start to
lose linearity (correlation coefficient R2 value starts and continue decreasing). Terminals with volumes greater than or equal to threshold are
classified as large terminals, and terminals with volume values that are smaller than the threshold are considered as small terminals. Threshold value
for (þ/þ) is 7 and (þ/) is 10 lm3. (H) Comparisons of small and large axons between CASK(þ/þ) and CASK(þ/) by terminal volume (bouton), data are
plotted as mean 6 SD; n ¼ 3.
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compartments.53,54 We have recently made two independent
observations, first, CASK stabilizes neuronal adhesion mole-
cule neurexin and links it to the signaling molecule liprin-a.55
Liprin-as are critical for photoreceptor axonal targeting in
drosophila56 as well as for forming active zones.57 Neurexins
themselves may play a critical role in intercellular adhesion
and signaling.58 A reduction in neurexin signaling and defect
in axonal targeting may produce ONH, secondary to defect at
the retinogeniculate synapses due to retrograde degenera-
tion.59 Second, CASK may regulate cellular metabolism
including mitochondrial respiration.24 Retina and optic nerve
are highly susceptible to metabolic defects, and mitochondri-
al damage and mutations in mitochondrial genes are
frequently associated with optic neuropathies.60 In fact, as
many as 12% cases of nonsyndromic mitochondrial cytopa-
thies may display ONH.61 Thus, a change in metabolic status
of retinal cells may also lead to ONH in CASK(þ/) mice and
CASK haploinsufficient girls.
Mutations in CASK have been associated with diagnosis of
both ONH and ONA. The difference between these two
conditions is often blurred and it has been speculated that
better imaging techniques may differentiate these conditions.
Many authorities even suggest that both ONH and ONA may be
similar pathology with the only difference being in their
FIGURE 6. CASK(þ/) mice optic nerve display secondary reduction in size. (A) Representative images of toluidine blue–stained semithin-sections
derived from optic nerve of indicated ages and genotypes. Scale bars: 100 lm. (B) Quantitation of optic nerve areas from mice of indicated age and
genotype. Data are plotted as mean 6 SEM, n¼ 3. (C) Quantitation of axonal density. Data are plotted as mean 6 SD. (*P < 0.05; **P < 0.01). (D)
Representative images of retinas from P6 mice stained with DAPI and RNA-RBPMS reveal no change in cell number in the ganglion cell layer of
CASK(þ/) mutants compared with controls. Scale bar: 25 lm. (E) Quantification of DAPI- and RBPMS-positive cells in the ganglion cell layer in P6
mutant and control retina.
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timing.5 What does our study reveal regarding the pathology of
optic nerve? First of all, we present case reports of CASK
haploinsufficiency displaying ONH, confirming the genetic
associations. Second, using a rodent model, we are able to
causally link ONH with CASK haploinsufficiency. Due to a
common underlying biology (CASK haploinsufficiency) and
similar optic nerve pathology CASK(þ/) mice satisfies the
criteria for ‘face validity’ of an animal model. Previous rodent
models of ONH using alcohol produced thinning of optic nerve
only during adulthood (after 9 weeks).62 In contrast, significant
decrease in optic nerve area in CASK(þ/) mice was observed as
early as P6, which corresponds to late third trimester in human
fetal development.21 The time period of optic nerve pathology
in CASK(þ/) mice is indeed developmental in nature, and is
therefore a superior rodent model of ONH. Several histopath-
ologic hallmarks of atrophy however are present in ONH such
as astrogliosis and thinning of axons. A detailed examination of
optic nerve, retina, and dLGN in CASK(þ/) mice undermine the
idea that simply better imaging tool may be able to distinguish
between ONH and ONA in human patients, these optic
neuropathies may not be amenable to straightforward binary
classification simply by morphology. We suggest that mutations
in CASK is typically associated with ONH, the diagnosis of ONA
may simply stem from the timing when originally uncovered.
In fact, many infants that are diagnosed with ONA may actually
have ONH, which was not diagnosed earlier.
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